Health ❯ Healthcare ❯ Research

Clinical Trials

Randomized Controlled Trials Alzheimer's Treatments Therapeutics Alzheimer's Research AI in Medicine Alzheimer's Disease Innovative Treatments Drug Development Observational Studies Biomarkers

Mirtazapine Modestly Cuts Meth Use in Phase III Trial

With no approved drugs for methamphetamine use disorder, the generic antidepressant offers a small, reproducible benefit that may inform care.

Mavacamten Cuts Heart Outflow Obstruction in Teens in First Randomized Trial

Long-Term Studies Link Lifelong Mental Engagement and Boosted Speed Training to Lower Dementia Risk

Stanford’s Broad-Acting Nasal Vaccine Shows Mouse Success as Human Trials Are Planned

Women’s Heart Risk Rises at Lower Coronary Plaque Burden in PROMISE CCTA Analysis

p‑Tau217 Blood Tests Boost Alzheimer’s Diagnosis and Predict Onset Within a Few Years

Ultrasound Plus Mammography Cuts Advanced Breast Cancers in Japanese Women in Their 40s

BioNTech’s Personalized mRNA Vaccine Shows Durable Immune Response in Triple-Negative Breast Cancer Phase 1

Umbrella Review Questions Exercise as First-Line Osteoarthritis Treatment

Two-Decade Trial Links Adaptive Speed Training to 25% Lower Dementia Risk

UK Regulator Adds Severe Pancreatitis Warning to Ozempic, Wegovy and Mounjaro

Amit Shah Inaugurates Patanjali’s 250-Bed Integrated Emergency Hospital in Haridwar

Smartwatches Spot Atrial Fibrillation Four Times More Often in Older Adults, Study Finds

Brazil Advances Injectable HIV PrEP Rollout, Explores Local Production After Fiocruz–Gilead Memorandum

UK Study Validates Finger-Prick Screening for Early Type 1 Diabetes, Prompting NHS Clinics

Finger‑Prick Alzheimer’s Blood Test Moves Forward in International Trial With 883 Enrolled

Kennedy Appoints Two OB-GYNs to CDC Vaccine Panel, Extending Overhaul of ACIP

Vegetable-Based Supplement Plus Probiotic Slows PSA Rise in Low-Risk Prostate Cancer

Mount Sinai's NutriSighT Predicts Underfeeding Risk in Ventilated ICU Patients

Shingles Vaccine Linked to Lower Dementia Risk and Fewer Deaths in New Analysis